Bausch Health extended a tender offer for shares of Durect.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bausch Health extended a tender offer for shares of Durect.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Acquisition between Durect and Bausch Health advances liver disease treatment.Sub-event
Bausch Health extended its tender offer for Durect shares.1 source
Keep exploring
The entities involved
-
Durect (United States)
company in Cupertino, United States
Nothing else this week.
-
Bausch Health
multinational specialty drugs company based in Laval, Quebec, Canada
Nothing else this week.
Coverage
Newest first; wire copies grouped- ACCESS NewswireBausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TS